11-67456449-C-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_145200.5(CABP4):​c.541+7C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,607,640 control chromosomes in the GnomAD database, including 162,322 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23141 hom., cov: 31)
Exomes 𝑓: 0.43 ( 139181 hom. )

Consequence

CABP4
NM_145200.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00003295
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.829

Publications

9 publications found
Variant links:
Genes affected
CABP4 (HGNC:1386): (calcium binding protein 4) This gene encodes a member of the CABP family of calcium binding protein characterized by four EF-hand motifs. Mutations in this gene are associated with congenital stationary night blindness type 2B. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
CABP4 Gene-Disease associations (from GenCC):
  • cone-rod synaptic disorder, congenital nonprogressive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-67456449-C-G is Benign according to our data. Variant chr11-67456449-C-G is described in ClinVar as Benign. ClinVar VariationId is 305654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.8 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CABP4NM_145200.5 linkc.541+7C>G splice_region_variant, intron_variant Intron 3 of 5 ENST00000325656.7 NP_660201.1 P57796-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CABP4ENST00000325656.7 linkc.541+7C>G splice_region_variant, intron_variant Intron 3 of 5 1 NM_145200.5 ENSP00000324960.5 P57796-1
CABP4ENST00000438189.6 linkc.226+7C>G splice_region_variant, intron_variant Intron 4 of 6 1 ENSP00000401555.2 P57796-2
CABP4ENST00000545777.1 linkn.*197+32C>G intron_variant Intron 3 of 3 3 ENSP00000439145.1 F5H3E8

Frequencies

GnomAD3 genomes
AF:
0.522
AC:
79119
AN:
151440
Hom.:
23104
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.808
Gnomad AMI
AF:
0.362
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.323
Gnomad EAS
AF:
0.294
Gnomad SAS
AF:
0.259
Gnomad FIN
AF:
0.374
Gnomad MID
AF:
0.357
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.473
GnomAD2 exomes
AF:
0.430
AC:
105195
AN:
244800
AF XY:
0.411
show subpopulations
Gnomad AFR exome
AF:
0.814
Gnomad AMR exome
AF:
0.579
Gnomad ASJ exome
AF:
0.320
Gnomad EAS exome
AF:
0.284
Gnomad FIN exome
AF:
0.371
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.415
GnomAD4 exome
AF:
0.429
AC:
624514
AN:
1456082
Hom.:
139181
Cov.:
60
AF XY:
0.421
AC XY:
304964
AN XY:
724324
show subpopulations
African (AFR)
AF:
0.820
AC:
27455
AN:
33466
American (AMR)
AF:
0.575
AC:
25566
AN:
44482
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
8329
AN:
26116
East Asian (EAS)
AF:
0.307
AC:
12191
AN:
39670
South Asian (SAS)
AF:
0.274
AC:
23587
AN:
86210
European-Finnish (FIN)
AF:
0.376
AC:
18224
AN:
48468
Middle Eastern (MID)
AF:
0.380
AC:
2189
AN:
5760
European-Non Finnish (NFE)
AF:
0.433
AC:
481165
AN:
1111588
Other (OTH)
AF:
0.428
AC:
25808
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
20696
41391
62087
82782
103478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14722
29444
44166
58888
73610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.523
AC:
79202
AN:
151558
Hom.:
23141
Cov.:
31
AF XY:
0.511
AC XY:
37854
AN XY:
74018
show subpopulations
African (AFR)
AF:
0.808
AC:
33367
AN:
41310
American (AMR)
AF:
0.503
AC:
7670
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
1119
AN:
3462
East Asian (EAS)
AF:
0.293
AC:
1496
AN:
5098
South Asian (SAS)
AF:
0.258
AC:
1246
AN:
4826
European-Finnish (FIN)
AF:
0.374
AC:
3929
AN:
10506
Middle Eastern (MID)
AF:
0.353
AC:
103
AN:
292
European-Non Finnish (NFE)
AF:
0.427
AC:
28955
AN:
67798
Other (OTH)
AF:
0.470
AC:
989
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1767
3535
5302
7070
8837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.448
Hom.:
3806
Bravo
AF:
0.551
Asia WGS
AF:
0.353
AC:
1228
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27259154) -

Mar 21, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cone-rod synaptic disorder, congenital nonprogressive Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
10
DANN
Benign
0.58
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000033
SpliceAI score (max)
0.48
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.48
Position offset: -3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1638564; hg19: chr11-67223920; COSMIC: COSV56886598; COSMIC: COSV56886598; API